Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

Dispatches from the Cell Therapy Manufacturing & Gene Therapy Congress

Bovine-derived media still 'gold standard' despite safety and reliability concerns, expert

Bovine-derived sera remain the gold standard in cell culture supplements despite its many flaws, says Cook Regentec.

Dispatches from Cell Therapy Manufacturing & Gene Therapy Congress

Vendors must collaborate to develop cell therapy production automation, experts

Cell therapy development and production will not be sustainable unless there is a vendor-led shift to automated processes, said experts in Brussels yesterday.

Japan’s PuRec to supply mesenchymal stem cells

Regenerative medicine developers now have a new supplier for mesenchymal stem cells, the multipotent stromal cells derived from marrow and other tissues like muscle and dental pulp for tissue repair.

‘Bleed to read’ tech will alter drug research and disease treatment, says CEO

Quanterix claims the updated version of its Simoa immunoassay platform allows biopharma researchers to study diseases in more detail than ever before.

Sandoz, Pfizer and regulators back biosimilar data extrapolation

Approving a biosimilar for the same diseases as the originator drug based on extrapolated data rather than study results should remain a cornerstone of the review process say regulators and developers.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...